Editorial Comment on Androgen Receptor Signaling Inhibitors in Nonmetastatic Castration-Resistant Prostate Cancer in Japan: The ARASHI Study. Hashizume A. Int J Urol 2025 Nov 17. doi: 10.1111/iju.70262.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hashizume A. Editorial Comment on Androgen Receptor Signaling Inhibitors in Nonmetastatic Castration-Resistant Prostate Cancer in Japan: The ARASHI Study. Int J Urol 2025 Nov 17. doi: 10.1111/iju.70262.
PMID: 41249868